Leadership perspectives in multidisciplinary team meetings; observational assessment based on the ATLAS instrument in cancer care
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Leadership perspectives in multidisciplinary team meetings; observational assessment based on the ATLAS instrument in cancer care. / Wihl, Jessica; Rosell, Linn; Bendahl, Pär Ola; De Mattos, Camila B.R.; Kinhult, Sara; Lindell, Gert; von Steyern, Fredrik Vult; Nilbert, Mef.
I: Cancer Treatment and Research Communications, Bind 25, 100231, 2020.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Leadership perspectives in multidisciplinary team meetings; observational assessment based on the ATLAS instrument in cancer care
AU - Wihl, Jessica
AU - Rosell, Linn
AU - Bendahl, Pär Ola
AU - De Mattos, Camila B.R.
AU - Kinhult, Sara
AU - Lindell, Gert
AU - von Steyern, Fredrik Vult
AU - Nilbert, Mef
PY - 2020
Y1 - 2020
N2 - Objectives: High-quality leadership and chairing skills are central components in team performance during multidisciplinary team (MDT) meetings. We hypothesized that the recently developed A Tumor Leadership Assessment inStrument (ATLAS) could provide relevant information to support more detailed insights into MDT chairing and leadership aspects of relevance for team feedback and targeted improvements. Materials and Methods: The observational assessment instrument ATLAS rates chairing and leadership skills during MDT meetings in 12 predefined domains that include e.g. time management, case prioritization, team involvement, discussion climate and clarity of treatment recommendations. We used ATLAS to prospectively assess 33 MDT meetings in neuro-oncology, sarcoma and hepatobiliary cancer. Results: The aspects time management, effective case prioritization and provision of clear treatment plans were found to be well-functioning, whereas facilitatation of case discussions, encouragment of team member contributions, keeping the meeting focused and ability to summarize case discussions showed variable and partly weak results. Conclusion: We conclude that the ATLAS instrument effectively captures various aspects of MDT leadership and chairing skills. It may thereby provide relevant information to prioritize initiatives that support and develop effective teamwork and decision-making during MDT meetings.
AB - Objectives: High-quality leadership and chairing skills are central components in team performance during multidisciplinary team (MDT) meetings. We hypothesized that the recently developed A Tumor Leadership Assessment inStrument (ATLAS) could provide relevant information to support more detailed insights into MDT chairing and leadership aspects of relevance for team feedback and targeted improvements. Materials and Methods: The observational assessment instrument ATLAS rates chairing and leadership skills during MDT meetings in 12 predefined domains that include e.g. time management, case prioritization, team involvement, discussion climate and clarity of treatment recommendations. We used ATLAS to prospectively assess 33 MDT meetings in neuro-oncology, sarcoma and hepatobiliary cancer. Results: The aspects time management, effective case prioritization and provision of clear treatment plans were found to be well-functioning, whereas facilitatation of case discussions, encouragment of team member contributions, keeping the meeting focused and ability to summarize case discussions showed variable and partly weak results. Conclusion: We conclude that the ATLAS instrument effectively captures various aspects of MDT leadership and chairing skills. It may thereby provide relevant information to prioritize initiatives that support and develop effective teamwork and decision-making during MDT meetings.
KW - Chairing
KW - Leadership
KW - Multidisciplinary team meeting
KW - Observational study
KW - Tumor board
U2 - 10.1016/j.ctarc.2020.100231
DO - 10.1016/j.ctarc.2020.100231
M3 - Journal article
C2 - 33157512
AN - SCOPUS:85094962677
VL - 25
JO - Cancer Treatment and Research Communications
JF - Cancer Treatment and Research Communications
SN - 2213-0896
M1 - 100231
ER -
ID: 260245703